Altimmune (ALT) Operating Margin (2016 - 2025)
Historic Operating Margin for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to 417180.0%.
- Altimmune's Operating Margin rose 781600000.0% to 417180.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 452310.0%, marking a year-over-year decrease of 2370619200.0%. This contributed to the annual value of 515860.0% for FY2024, which is 4933414600.0% down from last year.
- Altimmune's Operating Margin amounted to 417180.0% in Q3 2025, which was up 781600000.0% from 458440.0% recorded in Q2 2025.
- In the past 5 years, Altimmune's Operating Margin ranged from a high of 731.92% in Q4 2021 and a low of 1237600.0% during Q3 2022
- For the 5-year period, Altimmune's Operating Margin averaged around 292639.73%, with its median value being 254937.5% (2022).
- In the last 5 years, Altimmune's Operating Margin plummeted by 2000000000bps in 2022 and then soared by 2000000000bps in 2023.
- Altimmune's Operating Margin (Quarter) stood at 731.92% in 2021, then plummeted by -12036bps to 88823.08% in 2022, then fell by -2bps to 90872.97% in 2023, then plummeted by -447bps to 497320.0% in 2024, then grew by 16bps to 417180.0% in 2025.
- Its Operating Margin was 417180.0% in Q3 2025, compared to 458440.0% in Q2 2025 and 436300.0% in Q1 2025.